Xueting Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xueting Luo has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Xiaodong Sun
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
9 shared publications Jian Liang
Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University, School of Medicine, Shanghai 200080, China
8 shared publicationsYuanqi Zhai
Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China
7 shared publicationsHong Zhu
Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China
6 shared publicationsXiangjun She
Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
5 shared publicationsYang Liu
Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University, School of Medicine, Shanghai 200080, China
5 shared publications
Latest Publications
- 18 September 2021
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 14 (9) , 1334-1344
Deletion of prominin-1 in mice results in disrupted photoreceptor outer segment protein homeostasis
To illustrate the underlying mechanism how prominin-1 (also known as Prom1) mutation contribute to progressive photoreceptor degeneration. A CRISPR-mediated Prom1 knockout (Prom1-KO) mice model in the C57BL/6 was generated and the photoreceptor degeneration phenotypes by means of structural and functional tests were demonstrated. Immunohistochemistry and immunoblot analysis were performed to reveal the localization and quantity of related outer segment (OS) proteins. The Prom1-KO mice developed the photoreceptor degeneration phenotype including the decreased outer nuclear layer (ONL) thickness and compromised electroretinogram amplitude. Immunohistochemistry analysis revealed impaired trafficking of photoreceptor OS proteins. Immunoblot data demonstrated decreased photoreceptor OS proteins. Prom1 deprivation causes progressive photoreceptor degeneration. Prom1 is essential for maintaining normal trafficking and normal quantity of photoreceptor OS proteins. The new light is shed on the pathogenic mechanism underlying photoreceptor degeneration caused by Prom1 mutation.
- 18 September 2021
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 14 (9) , 1334-1344
Deletion of prominin-1 in mice results in disrupted photoreceptor outer segment protein homeostasis
To illustrate the underlying mechanism how prominin-1 (also known as Prom1) mutation contribute to progressive photoreceptor degeneration. A CRISPR-mediated Prom1 knockout (Prom1-KO) mice model in the C57BL/6 was generated and the photoreceptor degeneration phenotypes by means of structural and functional tests were demonstrated. Immunohistochemistry and immunoblot analysis were performed to reveal the localization and quantity of related outer segment (OS) proteins. The Prom1-KO mice developed the photoreceptor degeneration phenotype including the decreased outer nuclear layer (ONL) thickness and compromised electroretinogram amplitude. Immunohistochemistry analysis revealed impaired trafficking of photoreceptor OS proteins. Immunoblot data demonstrated decreased photoreceptor OS proteins. Prom1 deprivation causes progressive photoreceptor degeneration. Prom1 is essential for maintaining normal trafficking and normal quantity of photoreceptor OS proteins. The new light is shed on the pathogenic mechanism underlying photoreceptor degeneration caused by Prom1 mutation.
- 1 October 2020
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 36 (8) , 618-628
3-Methyladenine Alleviates Experimental Subretinal Fibrosis by Inhibiting Macrophages and M2 Polarization Through the PI3K/Akt Pathway
Purpose: To explore the effects of 3-methyladenine (3-MA), a selective inhibitor of phosphatidylinositol-3-kinase (PI3K), on experimental subretinal fibrosis (SRF) in mice. Methods: The SRF mouse model was established by 532 nm laser photocoagulation at each fundus of mice on day 0. 3-MA was administered every 2 days from day 0 to 35. Immunofluorescence of choroidal flat mounts was performed to evaluate the size of SRF area, local macrophages, and polarization, respectively. Besides, Western blot analysis was carried out to assess the expression levels of macrophage polarization-related genes, Arg-1, Ym-1, and transforming growth factor-β 2 (TGF-β 2 ). Co-culture and migration experiments were used to demonstrate the inhibitory effect of 3-MA on fibroblasts. The gene knockout and Western blot analysis were used to explore the signal pathways related to macrophage polarization. Results: Compared with the control group, the 3-MA-treated group showed significantly less size of SRF area. 3-MA treatment reduced both circulating and local macrophages, and counteracted M2 polarization. Moreover, 3-MA inhibited fibroblast recruitment. Mechanistically, we proved that 3-MA inhibits macrophage M2 polarization by suppressing PI3K/Akt signal pathway rather than the PI3K-autophagy-related signal pathway. Conclusions: 3-MA exerts antifibrotic effects on experimental SRF by targeting circulating and local macrophages and M2 polarization, through PI3K/Akt signal pathway. These results support the potential use of 3-MA as a new therapeutic modality for SRF associated with neovascular age-related macular degeneration.
- 1 October 2020
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 36 (8) , 618-628
3-Methyladenine Alleviates Experimental Subretinal Fibrosis by Inhibiting Macrophages and M2 Polarization Through the PI3K/Akt Pathway
Purpose: To explore the effects of 3-methyladenine (3-MA), a selective inhibitor of phosphatidylinositol-3-kinase (PI3K), on experimental subretinal fibrosis (SRF) in mice. Methods: The SRF mouse model was established by 532 nm laser photocoagulation at each fundus of mice on day 0. 3-MA was administered every 2 days from day 0 to 35. Immunofluorescence of choroidal flat mounts was performed to evaluate the size of SRF area, local macrophages, and polarization, respectively. Besides, Western blot analysis was carried out to assess the expression levels of macrophage polarization-related genes, Arg-1, Ym-1, and transforming growth factor-β 2 (TGF-β 2 ). Co-culture and migration experiments were used to demonstrate the inhibitory effect of 3-MA on fibroblasts. The gene knockout and Western blot analysis were used to explore the signal pathways related to macrophage polarization. Results: Compared with the control group, the 3-MA-treated group showed significantly less size of SRF area. 3-MA treatment reduced both circulating and local macrophages, and counteracted M2 polarization. Moreover, 3-MA inhibited fibroblast recruitment. Mechanistically, we proved that 3-MA inhibits macrophage M2 polarization by suppressing PI3K/Akt signal pathway rather than the PI3K-autophagy-related signal pathway. Conclusions: 3-MA exerts antifibrotic effects on experimental SRF by targeting circulating and local macrophages and M2 polarization, through PI3K/Akt signal pathway. These results support the potential use of 3-MA as a new therapeutic modality for SRF associated with neovascular age-related macular degeneration.
- Open Access
- 1 July 2020
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 61 (8) , 31
Photoreceptors Degenerate Through Pyroptosis After Experimental Retinal Detachment
Purpose: Gasdermin D (GSDMD) is crucial in neuronal pyroptosis. GSDMD-N and GSDMD-C are two subdomains of the protein GSDMD. GSDMD-N is an executor of pyroptosis, and GSDMD-C has an inhibitory effect on pyroptotic cell death. This study evaluated the role of GSDMD in photoreceptor cell pyroptosis caused by retinal detachment (RD). Methods: RD models were established in rats, and GSDMD cleavage was detected by western blotting. The morphology of photoreceptors was assessed by transmission electron microscopy. Some rats were given subretinal injections of recombinant adeno-associated virus 2/8 (rAAV2/8)–GSDMD-C before RD surgery. We documented the expression of caspase-1 and GSDMD-N in retinas by western blot. Levels of IL-1β, TNF-α, and monocyte chemoattractant protein-1 (MCP-1) were detected by quantitative RT-PCR. The membrane integrity of photoreceptors was evaluated by TOTO-3 iodide staining. Retinal function was measured by electroretinography, and the thickness of the outer nuclear layer was also recorded. We measured the activation of glial fibrillary acidic protein (GFAP), F4/80, and ionized calcium binding adaptor molecule 1 (Iba-1) by immunofluorescence. Results: The cleavage of GSDMD peaked at 1 day after RD. The administration of rAAV2/8–GSDMD-C reduced the pyroptosis and subsequent apoptosis of photoreceptors and preserved the retinal function after RD. Expression of IL-1, TNF-α, and MCP-1 was decreased in the rAAV2/8–GSDMD-C group. In addition, the activation of GFAP, Iba-1, and F4/80 in retinas was alleviated by administering rAAV2/8–GSDMD-C after RD. Conclusions: GSDMD participates in the pyroptosis of photoreceptor after RD. Overexpression of GSDMD-C may block GSDMD cleavage and attenuate photoreceptor degeneration.
- 1 July 2020
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 61 (8) , 31
Open AccessPhotoreceptors Degenerate Through Pyroptosis After Experimental Retinal Detachment
Purpose: Gasdermin D (GSDMD) is crucial in neuronal pyroptosis. GSDMD-N and GSDMD-C are two subdomains of the protein GSDMD. GSDMD-N is an executor of pyroptosis, and GSDMD-C has an inhibitory effect on pyroptotic cell death. This study evaluated the role of GSDMD in photoreceptor cell pyroptosis caused by retinal detachment (RD). Methods: RD models were established in rats, and GSDMD cleavage was detected by western blotting. The morphology of photoreceptors was assessed by transmission electron microscopy. Some rats were given subretinal injections of recombinant adeno-associated virus 2/8 (rAAV2/8)–GSDMD-C before RD surgery. We documented the expression of caspase-1 and GSDMD-N in retinas by western blot. Levels of IL-1β, TNF-α, and monocyte chemoattractant protein-1 (MCP-1) were detected by quantitative RT-PCR. The membrane integrity of photoreceptors was evaluated by TOTO-3 iodide staining. Retinal function was measured by electroretinography, and the thickness of the outer nuclear layer was also recorded. We measured the activation of glial fibrillary acidic protein (GFAP), F4/80, and ionized calcium binding adaptor molecule 1 (Iba-1) by immunofluorescence. Results: The cleavage of GSDMD peaked at 1 day after RD. The administration of rAAV2/8–GSDMD-C reduced the pyroptosis and subsequent apoptosis of photoreceptors and preserved the retinal function after RD. Expression of IL-1, TNF-α, and MCP-1 was decreased in the rAAV2/8–GSDMD-C group. In addition, the activation of GFAP, Iba-1, and F4/80 in retinas was alleviated by administering rAAV2/8–GSDMD-C after RD. Conclusions: GSDMD participates in the pyroptosis of photoreceptor after RD. Overexpression of GSDMD-C may block GSDMD cleavage and attenuate photoreceptor degeneration.
- 1 April 2020
- Published by Elsevier in Experimental Eye Research
- Vol. 193, 107949
An improved method for establishment of murine retinal detachment model and its 3D vascular evaluation
- 1 April 2020
- Published by Elsevier in Experimental Eye Research
- Vol. 193, 107949
An improved method for establishment of murine retinal detachment model and its 3D vascular evaluation
- Open Access
- 23 October 2019
- Published by Wiley in The FASEB Journal
- Vol. 33 (12) , 13920-13934
Intraocular VEGF deprivation induces degeneration and fibrogenic response in retina
VEGF is a critical driver of ocular neovascularization under disease conditions. Current therapeutic strategies rely on intraocular delivery of VEGF‐antagonizing reagents, which results in sustained suppression of pathogenic vascularization. Although significant advancement has been achieved in VEGF antagonism, substantial adverse effects have been reported in retrospective clinical studies. To study mechanisms for VEGF antagonism‐associated adverse effects in visual system, we intravitreally delivered recombinant adeno‐associated virusmediated expression of soluble Fms‐related tyrosine kinase‐1 (rAAV.sFLT‐1), the extracellular domain of VEGF receptor, and analyzed the morphology and functions of retinal tissue. Here, we confirmed that intraocular VEGF antagonism induced retinal degeneration and gliosis. The functional deficit in retinal response to visual stimulation was also demonstrated in rAAV.sFLT‐1‐treated eyes by electroretinogram. Moreover, high‐throughput RNA sequencing analysis suggests that VEGF antagonism activates retinal degeneration, inflammation, and other adverse effects. Taken together, our findings have shed light on pathogenic mechanisms for VEGF antagonism‐associated adverse effects and potential therapeutic targets.—Xiao, M., Liu, Y., Wang L., Liang, J., Wang T., Zhai, Y., Wang Y., Liu S. Liu W. Luo X. Wang F. Sun X. Intraocular VEGF deprivation induces degeneration and fibrogenic response in retina. FASEB J. 33, 13920‐13934 (2019). www.fasebj.org
- 23 October 2019
- Published by Wiley in The FASEB Journal
- Vol. 33 (12) , 13920-13934
Open AccessIntraocular VEGF deprivation induces degeneration and fibrogenic response in retina
VEGF is a critical driver of ocular neovascularization under disease conditions. Current therapeutic strategies rely on intraocular delivery of VEGF‐antagonizing reagents, which results in sustained suppression of pathogenic vascularization. Although significant advancement has been achieved in VEGF antagonism, substantial adverse effects have been reported in retrospective clinical studies. To study mechanisms for VEGF antagonism‐associated adverse effects in visual system, we intravitreally delivered recombinant adeno‐associated virusmediated expression of soluble Fms‐related tyrosine kinase‐1 (rAAV.sFLT‐1), the extracellular domain of VEGF receptor, and analyzed the morphology and functions of retinal tissue. Here, we confirmed that intraocular VEGF antagonism induced retinal degeneration and gliosis. The functional deficit in retinal response to visual stimulation was also demonstrated in rAAV.sFLT‐1‐treated eyes by electroretinogram. Moreover, high‐throughput RNA sequencing analysis suggests that VEGF antagonism activates retinal degeneration, inflammation, and other adverse effects. Taken together, our findings have shed light on pathogenic mechanisms for VEGF antagonism‐associated adverse effects and potential therapeutic targets.—Xiao, M., Liu, Y., Wang L., Liang, J., Wang T., Zhai, Y., Wang Y., Liu S. Liu W. Luo X. Wang F. Sun X. Intraocular VEGF deprivation induces degeneration and fibrogenic response in retina. FASEB J. 33, 13920‐13934 (2019). www.fasebj.org
- 1 March 2019
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 96, 134-139
UMSC-derived exosomes promote retinal ganglion cells survival in a rat model of optic nerve crush
- 1 March 2019
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 96, 134-139
UMSC-derived exosomes promote retinal ganglion cells survival in a rat model of optic nerve crush
- 27 December 2018
- Published by Wiley in British Journal of Pharmacology
- Vol. 176 (6) , 801-813
Modulation of α‐adrenoceptor signalling protects photoreceptors after retinal detachment by inhibiting oxidative stress and inflammation
Background and Purpose: Currently available treatments do not halt progression of photoreceptor death and subsequent visual impairment related to retinal detachment (RD) which is observed in various retinal disorders. This study investigated the neuroprotective effects of two adrenoceptor ligands, the α1‐adrenoceptor antagonist doxazosin and the α2‐adrenoceptor agonist guanabenz, against photoreceptor cell death in RD.Experimental Approach: We used a model of experimental RD in Brown‐Norway rats induced by subretinal injection of sodium hyaluronate. Oxidative stress biomarkers and cytokine production were quantified with elisa. Protein expression levels and immunofluorescent labelling were determined in rats with RD and controls for mechanistic elucidation. The effects of systemic (i.p.) administration of doxazosin or guanabenz on photoreceptor apoptosis, retinal histology and electroretinography were evaluated in rats with RD and compared to the effects in vehicle controls.Key Results: Photoreceptors were the major source of RD‐induced ROS overproduction in the rat retina through the regulation of NADPH oxidase. Systemic administration of doxazosin or guanabenz decreased the RD‐induced production of ROS and proinflammatory cytokines, including IL‐1β and the chemokine CCL2, and suppressed retinal gliosis, resulting in attenuation of photoreceptor death and preservation of retinal structures and functions in RD.Conclusions and Implications: Our findings point to α‐adrenoceptors as novel therapeutic targets to provide photoreceptor protection and suggest that both doxazosin and guanabenz, two FDA‐approved drugs, could be further explored to treat retinal diseases.
- 27 December 2018
- Published by Wiley in British Journal of Pharmacology
- Vol. 176 (6) , 801-813
Modulation of α‐adrenoceptor signalling protects photoreceptors after retinal detachment by inhibiting oxidative stress and inflammation
Background and Purpose: Currently available treatments do not halt progression of photoreceptor death and subsequent visual impairment related to retinal detachment (RD) which is observed in various retinal disorders. This study investigated the neuroprotective effects of two adrenoceptor ligands, the α1‐adrenoceptor antagonist doxazosin and the α2‐adrenoceptor agonist guanabenz, against photoreceptor cell death in RD.Experimental Approach: We used a model of experimental RD in Brown‐Norway rats induced by subretinal injection of sodium hyaluronate. Oxidative stress biomarkers and cytokine production were quantified with elisa. Protein expression levels and immunofluorescent labelling were determined in rats with RD and controls for mechanistic elucidation. The effects of systemic (i.p.) administration of doxazosin or guanabenz on photoreceptor apoptosis, retinal histology and electroretinography were evaluated in rats with RD and compared to the effects in vehicle controls.Key Results: Photoreceptors were the major source of RD‐induced ROS overproduction in the rat retina through the regulation of NADPH oxidase. Systemic administration of doxazosin or guanabenz decreased the RD‐induced production of ROS and proinflammatory cytokines, including IL‐1β and the chemokine CCL2, and suppressed retinal gliosis, resulting in attenuation of photoreceptor death and preservation of retinal structures and functions in RD.Conclusions and Implications: Our findings point to α‐adrenoceptors as novel therapeutic targets to provide photoreceptor protection and suggest that both doxazosin and guanabenz, two FDA‐approved drugs, could be further explored to treat retinal diseases.
- 26 December 2018
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 257 (3) , 619-628
Identification of novel PROM1 mutations responsible for autosomal recessive maculopathy with rod-cone dystrophy
To characterize two patients with macular and rod-cone dystrophy and identify the genetic basis for disease.
- 26 December 2018
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 257 (3) , 619-628
Identification of novel PROM1 mutations responsible for autosomal recessive maculopathy with rod-cone dystrophy
To characterize two patients with macular and rod-cone dystrophy and identify the genetic basis for disease.
- 1 July 2018
- Published by Elsevier in The American Journal of Pathology
- Vol. 188 (7) , 1713-1722
Inhibition of Mitochondrial Fission Preserves Photoreceptors after Retinal Detachment
- 1 July 2018
- Published by Elsevier in The American Journal of Pathology
- Vol. 188 (7) , 1713-1722
Inhibition of Mitochondrial Fission Preserves Photoreceptors after Retinal Detachment
- 1 February 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 496 (4) , 1148-1154
Autophagy activated by SIRT6 regulates Aβ induced inflammatory response in RPEs
- 1 February 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 496 (4) , 1148-1154
Autophagy activated by SIRT6 regulates Aβ induced inflammatory response in RPEs